Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer

por van Eerden, Ruben A G, Mathijssen, Ron H J, Koolen, Stijn L W
Publicado 2020

Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics

por de Man, Femke M., Goey, Andrew K. L., van Schaik, Ron H. N., Mathijssen, Ron H. J., Bins, Sander
Publicado 2018

Feasibility of Extrapolating Randomly Taken Plasma Samples to Trough Levels for Therapeutic Drug Monitoring Purposes of Small Molecule Kinase Inhibitors

por van Eerden, Ruben A. G., Oomen-de Hoop, Esther, Noordam, Aad, Mathijssen, Ron H. J., Koolen, Stijn L. W.
Publicado 2021

Inhibiting CDK4/6 in Breast Cancer with Palbociclib, Ribociclib, and Abemaciclib: Similarities and Differences

por Braal, C. Louwrens, Jongbloed, Elisabeth M., Wilting, Saskia M., Mathijssen, Ron H. J., Koolen, Stijn L. W., Jager, Agnes
Publicado 2020

Tamoxifen use and potential effects on liver parenchyma: A long‐term prospective transient elastographic evaluation

por Braal, C. Louwrens, de Knegt, Robert J., Jager, Agnes, Koolen, Stijn L. W., Mathijssen, Ron H. J., Eechoute, Karel
Publicado 2022

Integrated Data Analysis of Six Clinical Studies Points Toward Model-Informed Precision Dosing of Tamoxifen

por Klopp-Schulze, Lena, Mueller-Schoell, Anna, Neven, Patrick, Koolen, Stijn L. W., Mathijssen, Ron H. J., Joerger, Markus, Kloft, Charlotte
Publicado 2020

Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma

por Hurkmans, Daan P, Jensen, Christina, Koolen, Stijn L W, Aerts, Joachim, Karsdal, Morten Asser, Mathijssen, Ron H J, Willumsen, Nicholas
Publicado 2020

Clinical CYP2D6 Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a Controversy

por Mulder, Tessa A. M., de With, Mirjam, del Re, Marzia, Danesi, Romano, Mathijssen, Ron H. J., van Schaik, Ron H. N.
Publicado 2021

Treatment and Implications of Vascular Endothelial Growth Factor Inhibitor‐Induced Blood Pressure Rise: A Clinical Cohort Study

por van Dorst, Daan C. H., Kabadayi, Sumeyye, Oomen‐de Hoop, Esther, Danser, A.H. Jan, Mathijssen, Ron H. J., Versmissen, Jorie
Publicado 2022

Pharmacokinetic Optimization of Everolimus Dosing in Oncology: A Randomized Crossover Trial

por Verheijen, Remy B., Atrafi, Florence, Schellens, Jan H. M., Beijnen, Jos H., Huitema, Alwin D. R., Mathijssen, Ron H. J., Steeghs, Neeltje
Publicado 2017

Prospective Analysis in GIST Patients on the Role of Alpha-1 Acid Glycoprotein in Imatinib Exposure

por Bins, Sander, Eechoute, Karel, Kloth, Jacqueline S. L., de Man, Femke M., Oosten, Astrid W., de Bruijn, Peter, Sleijfer, Stefan, Mathijssen, Ron H. J.
Publicado 2016

Clinically relevant drug interactions with multikinase inhibitors: a review

por Hussaarts, Koen G. A. M., Veerman, G. D. Marijn, Jansman, Frank G. A., van Gelder, Teun, Mathijssen, Ron H. J., van Leeuwen, Roelof W. F.
Publicado 2019

Therapeutic Drug Monitoring-Guided Adjuvant Tamoxifen Dosing in Patients with Early Breast Cancer: A Cost-Effectiveness Analysis from the Prospective TOTAM Trial

por Braal, C. Louwrens, Kleijburg, Anne, Jager, Agnes, Koolen, Stijn L. W., Mathijssen, Ron H. J., Corro Ramos, Isaac, Wetzelaer, Pim, Uyl-de Groot, Carin A.
Publicado 2022

Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology

por van der Kleij, Maud B. A., Guchelaar, Niels A. D., Mathijssen, Ron H. J., Versluis, Jurjen, Huitema, Alwin D. R., Koolen, Stijn L. W., Steeghs, Neeltje
Publicado 2023

Physiologically based pharmacokinetic/pharmacodynamic model for the prediction of morphine brain disposition and analgesia in adults and children

por Verscheijden, Laurens F. M., Litjens, Carlijn H. C., Koenderink, Jan B., Mathijssen, Ron H. J., Verbeek, Marcel M., de Wildt, Saskia N., Russel, Frans G. M.
Publicado 2021

Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patients

por Oosten, Astrid W., Abrantes, João A., Jönsson, Siv, de Bruijn, Peter, Kuip, Evelien J. M., Falcão, Amílcar, van der Rijt, Carin C. D., Mathijssen, Ron H. J.
Publicado 2016

Meta-analysis on the association of VEGFR1 genetic variants with sunitinib outcome in metastatic renal cell carcinoma patients

por Liu, Xiaoyan, Swen, Jesse J., Boven, Epie, Castellano, Daniel, Gelderblom, Hans, Mathijssen, Ron H.J., Rodríguez-Antona, Cristina, García-Donas, Jesus, Rini, Brian I., Guchelaar, Henk-Jan
Publicado 2016

Suitability of tumor-associated antibodies as predictive biomarker for response to immune checkpoint inhibitors in patients with melanoma: a short report

por de Joode, Karlijn, Veenbergen, Sharon, Kransse, Claudia, Kortleve, Dian, Debets, Reno, Mathijssen, Ron H J, Joosse, Arjen, Schreurs, Marco W J, Van der Veldt, Astrid A M
Publicado 2023

Tumor Volume as an Alternative Response Measurement for Imatinib Treated GIST Patients

por Schiavon, Gaia, Ruggiero, Alessandro, Schöffski, Patrick, van der Holt, Bronno, Bekers, Dave J., Eechoute, Karel, Vandecaveye, Vincent, Krestin, Gabriel P., Verweij, Jaap, Sleijfer, Stefan, Mathijssen, Ron H. J.
Publicado 2012

Correction: Tumor Volume as an Alternative Response Measurement for Imatinib Treated GIST Patients

por Schiavon, Gaia, Ruggiero, Alessandro, Schöffski, Patrick, van der Holt, Bronno, Bekers, Dave J., Eechoute, Karel, Vandecaveye, Vincent, Krestin, Gabriel P., Verweij, Jaap, Sleijfer, Stefan, Mathijssen, Ron H. J.
Publicado 2013